Background: Arterial remodelling has been related to clinical presentation and positively
INTRODUCTION
Vascular remodelling was described by Glagov as a compensatory enlargement of the coronary arteries in response to an increase in plaque area 1 . This concept has further evolved to a dynamic theory where vessels may also shrink in response to plaque growth 2 . This remodelling modality has been related to a more stable phenotype and clinical presentation [3] [4] [5] [6] , whereas several studies showed an increase in inflammatory marker levels, larger lipid cores and pronounced medial thinning in positive remodelled vessels 4, 5, 7 .
Recently, retrospective pathological studies have identified morphological and compositional features characteristic of plaque rupture 8, 9 . This has lead to a new classification of coronary lesions that illustrates plaque progression in a more comprehensive manner 9 .
Gray-scale intravascular ultrasound (IVUS) is of limited value for identification of specific plaque components 10 . However, spectral analysis of IVUS radiofrequency data (IVUS-Virtual Histology) has demonstrated the potential to provide detailed quantitative information on plaque composition and has been validated in studies of explanted human coronary segments 11 .
In this study, we sought to evaluate in vivo the relationship between plaque composition and coronary artery remodelling using ultrasound radiofrequency data analysis. In addition, we classified lesions with respect to its morphology 9 and evaluated the potential relationship between lesion type and coronary remodelling.
METHODS

Patients
Forty-one consecutive patients were retrospectively selected after screening a 54 patient database where non-culprit, angiographically non-obstructive (<50 %), ≤ 20 mm, non ostial lesions were investigated with IVUS. Diffusely diseased vessels and the lack of the presence of a lesion occluding ≥ 40% of the cross sectional area precluded the inclusion in this study. Lesions located in proximal and mid segments of a coronary artery were included in the study.
Major exclusion criteria included coronary anatomy that precluded safe intravascular ultrasonographic examination of a suitable region of interest. Informed, written consent was obtained from all the patients.
IVUS-VH Acquisition and Analysis
Details regarding the validation of the technique, on explanted human coronary segments, have previously been reported 11 . Briefly, IVUS-VH uses spectral analysis of IVUS radiofrequency data to construct tissue maps that classify plaque into four major components. In preliminary in vitro studies, four histological plaque components (fibrous, fibrolipid, lipid core and calcium) were correlated with a specific spectrum of the radiofrequency signal 11 . These different plaque components were assigned colour codes. Calcified, fibrous, fibrolipidic and lipid core regions were labeled white, green, greenish-yellow and red respectively.
IVUS-VH data was acquired after intracoronary administration of nitrates using a continuous pullback (0. 12, 13 . Compositional data of the minimal lumen area (MLA) were expressed as percentage of the plaque cross sectional area (CSA) corresponding to each plaque component.
The MLA site and a reference ≤ 10 mm proximal to the lesion were selected. There were no major side-branches between MLA and reference sites.
Remodelling was assessed using the remodelling index (RI), expressed as the EEM CSA (MLA site) / EEM CSA (reference's ) as previously described 6, 14, 15 , where EEM refers to the external elastic membrane.
We defined positive remodelling as RI ≥ 1.05 and negative remodelling as RI ≤ 0.95.
Values in between were considered neutral (no remodelling). Percentage stenosis of the minimal luminal area (MLA) site was defined as:
Vessel area MLA -Lumen area MLA/Vessel area MLA, x 100.
In accordance with previously reported data, we classified lesions into pathological intimal thickening (mainly fibrotic-fibrolipidic tissue, with lipid core comprising from 0% to < 3% of the CSA), fibrocalcific lesions (featuring mainly fibrotic plaques, with some calcium and a lipid core occupying between 3% and 10% of the CSA), fibrous cap atheroma [lipid-rich (>10% CSA) plaques with overlying fibrous tissue] and thin-cap fibroatheroma [lipid-rich (>10% CSA) plaques with no overlying fibrous tissue]. Figure 1 depicts examples of this classification. In order to classify lesions as such, the above criteria had to be met in the MLA site plus the immediate distal and proximal crosssections. Since the axial resolution of this technique is between 100-150 um, we assumed that the absence of fibrous tissue overlying a lipid core suggested a cap thickness of below 100-150 um 16 .
Statistical Analysis
Discrete variables are presented as counts and percentages. Continuous variables are presented as means ± SD. We looked for correlations between RI and both plaque components and percentage stenosis MLA using Pearson correlation coefficients.
Differences in means among groups were analyzed by a two-sided t-test or by one-way analysis of variance. We compared frequencies with the X 2 test. A p value of less than 0.05 indicated statistical significance. Statistical analyses were performed with use of SPSS software version 11.5.
RESULTS
Patient characteristics are shown in Recently, the relationship between vascular remodelling and plaque composition was assessed using Intravascular ultrasound (IVUS) [17] [18] [19] [20] . This catheter-based diagnostic tool provides an accurate tomographic view of the coronary arteries and has shown a high correlation with histology samples in in-vitro validation studies [21] [22] [23] . 25, 26 .
Conversely, negative remodelled vessels showed predominantly fibrotic plaques. In addition, in line with previously reported data, lesions with negative remodelling were related to higher degree of stenosis 2, 17, 27 . The findings of this study are consistent with previous pathological findings in sudden death patients 5 . However, such post-mortem studies do not have implications in the natural history of high-risk plaques and thus in the clinical outcome of patients. On the contrary, we strongly believe that the identification of these high-risk plaques in vivo could provide more insights into the prognosis and natural history of such lesions and into the effect of conventional and emerging antiatherosclerotic pharmacologic interventions.
Limitations
Since this was a cross sectional study and atherosclerosis is usually a diffuse disease, finding a fully non-diseased reference is not guaranteed. Therefore, we cannot rule out the early presence of remodelling in the reference site. In addition, this is a pilot study that needs further confirmation in a larger population. Moreover, lesion type classification performed by this technique lacks the accuracy of histopathology, since resolution is inferior. Nevertheless, a significant relationship was found using this arbitrary classification. Although histopathology remains the gold standard, this technique has the potential to provide real time accurate information regarding tissue characterization and plaque morphology.
Conclusions
In this small clinical study, in vivo plaque composition and morphology assessed using spectral analysis of IVUS radiofrequency data was related to coronary artery remodelling, supporting the role of plaque composition in the mechanisms of vessel remodelling. Lipid core size was significantly larger in coronary lesions that undergo positive remodelling than in those that experience vessel shrinkage. Furthermore, the fibrotic burden of the plaque was significantly and inversely correlated to the remodelling index. The findings of this study are consistent with previous pathological findings. However, post-mortem studies do not have potential to provide prospective information about the natural history of high-risk plaques. On the contrary, we strongly believe that the identification of these high-risk plaques in vivo could provide more insights into the prognosis and natural history of such lesions and into the effect of conventional and emerging antiatherosclerotic pharmacologic interventions. mg/dl or treatment for hypercholesterolemia. ** These patients were studied at scheduled follow-up angiography. Table 2 Geometrical and compositional data of the minimal lumen area site. 
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